NCT01882088View on ClinicalTrials.gov

Phase IV Study of the Impact of Dietary Fibers on Symptoms and Esophageal Motility in Patients With Non-erosive GERD

PHASE4CompletedINTERVENTIONAL

Enrollment

36

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

September 30, 2016

Study Completion Date

December 31, 2016

Conditions

Gastroesophageal Reflux Disease

Interventions

DRUG

Mucofalk

Mucofalk 15 g/day i.e. 5 g TID per os, 15-20 min before meal

Trial Locations (1)

115446

Research Institute of Nutrition of Russian Academy of Medical Sciences, Moscow

Sponsors

Collaborators (1)

Dr. Falk Pharma GmbH

All Listed Sponsors

collaborator

Dr. Falk Pharma GmbH

INDUSTRY

lead

Russian Academy of Medical Sciences

OTHER